Overactive Bladder
Test - retest reliability of the Indonesian version of the Overactive Bladder Symptom Score (OABSS) and its correlation with standard assessment tools - Abstract
September 25, 2012
Oxybutynin: Past, present, and future - Abstract
September 24, 2012
Correlation of ultrasound-estimated bladder weight to urodynamic diagnoses in women with lower urinary tract symptoms - Abstract
September 20, 2012
Intradetrusor injection of botulinum toxin for the management of refractory overactive bladder syndrome: An update - Abstract
September 19, 2012
Urodynamic differences between dysfunctional voiding and primary bladder neck obstruction in women - Abstract
September 18, 2012
Content validity and test-retest reliability of patient perception of intensity of urgency scale (PPIUS) for overactive bladder - Abstract
September 17, 2012
Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity - Abstract
September 17, 2012
Analysis of the risk factors for overactive bladder on the basis of a survey in the community - Abstract
September 11, 2012
Single dose pharmacokinetics and absolute bioavailability of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder - Abstract
September 10, 2012
Association of symptoms with urodynamic findings in men with overactive bladder syndrome - Abstract
September 7, 2012
Sacral neuromodulation and intravesical botulinum toxin for refractory overactive bladder - Abstract
September 6, 2012
International prostate symptom score for assessing lower urinary tract dysfunction in women - Abstract
September 4, 2012
Has the cost of anti-muscarinic a key role in the success rate of patients diagnosed with overactive bladder syndrome? - Abstract
September 4, 2012